{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:02:39Z","timestamp":1784343759404,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.farma.2025.09.005","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:42:36Z","timestamp":1769604156000},"page":"T204-T207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Multidisciplinary approach to prenatal cystic fibrosis with cystic fibrosis transmembrane regulator modulators: Experience in a clinical case"],"prefix":"10.1016","volume":"50","author":[{"given":"Pedro","family":"del Palacio-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00eda-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Canales-Siguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Luna-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Salcedo-Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Huecas-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota Esperanza","family":"Vaquer-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Ferrari-Piquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.farma.2025.09.005_bb0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-med-042120-020148","article-title":"Clinical phenotypes of cystic fibrosis carriers","volume":"73","author":"Polgreen","year":"2022","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.farma.2025.09.005_bb0010","first-page":"215","article-title":"Fibrosis qu\u00edstica: patogenia bacteriana y moduladores del CFTR (regulador de conductancia transmembranal de la fibrosis qu\u00edstica)","volume":"79","author":"Vargas-Rold\u00e1n","year":"2022","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"4","key":"10.1016\/j.farma.2025.09.005_bb0015","doi-asserted-by":"crossref","first-page":"251.e1","DOI":"10.1016\/j.anpedi.2018.11.009","article-title":"Protocolo de seguimiento de pacientes con fibrosis qu\u00edstica diagnosticados por cribado neonatal","volume":"90","author":"Gartner","year":"2019","journal-title":"An Pediatr"},{"issue":"2","key":"10.1016\/j.farma.2025.09.005_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000530261","article-title":"Prenatal cystic fibrosis transmembrane conductance regulator modulator therapy: a promising way to change the impact of cystic fibrosis","volume":"50","author":"G\u00f3mez-Montes","year":"2023","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.farma.2025.09.005_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","article-title":"Maternal and fetal outcomes following elexacaftor-tezacaftor- ivacaftor use during pregnancy and lactation","volume":"20","author":"Taylor-Cousar","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"457","key":"10.1016\/j.farma.2025.09.005_bb0030","first-page":"465","article-title":"First real world study of fetal therapy with CFTR modulators in cystic fibrosis: report from the MODUL CF study","volume":"24","author":"Bonnel","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.farma.2025.09.005_bb0035","first-page":"47","article-title":"Pregnancy in people with cystic fibrosis treated with highly effective modulator therapy: maternal and fetal outcomes","volume":"23","author":"Goralski","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.farma.2025.09.005_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","article-title":"A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.farma.2025.09.005_bb0045","article-title":"Monitoring ETI effects over 1.7 years in an infant treated in utero, via breast milk and granules by repeated faecal elastase measurements","volume":"24","author":"Appelt","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.farma.2025.09.005_bb0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.farma.2025.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2024.06.003","article-title":"Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies","volume":"23","author":"Kowalik","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.farma.2025.09.005_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","article-title":"Measured fetal and neonatal exposure to lumacaftor and ivacaftor during pregnancy and while breastfeeding","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.farma.2025.09.005_bb0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.12.004","article-title":"Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor","volume":"21","author":"Collins","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.farma.2025.09.005_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcf.2020.02.018","article-title":"Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators \u2013 an international survey","volume":"19","author":"Nash","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.farma.2025.09.005_bb0075","unstructured":"U.S. National Library of Medicine. Drugs and lactation database (LactMed). Bethesda (MD): National Institutes of Health. [accessed 6 Ago 2025]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/"},{"issue":"3","key":"10.1016\/j.farma.2025.09.005_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.farma.2025.09.005_bb0085","unstructured":"Asociaci\u00f3n M\u00e9dica Mundial. Declaraci\u00f3n de Helsinki de la AMM \u2013 Principios \u00e9ticos para las investigaciones m\u00e9dicas en participantes humanos; 2024. [accessed 1 May 2025]. Available from: https:\/\/www.wma.net\/es\/policies-post\/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos\/."}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325002132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325002132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:19:10Z","timestamp":1784341150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325002132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1130634325002132"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.09.005","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Multidisciplinary approach to prenatal cystic fibrosis with cystic fibrosis transmembrane regulator modulators: Experience in a clinical case","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.09.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}